Journal of Virology, March 2000, p. 2804-2813, Vol. 74, No. 6
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Department of Respiratory Medicine and Allergy, The Guy's, King's College, and St. Thomas' Hospitals School of Medicine,1 and The Randall Institute, King's College London,2 London SE1 9RT, United Kingdom, and GenVec Inc., Rockville, Maryland 208523
Received 30 September 1999/Accepted 13 December 1999
The binding of adenovirus (Ad) fiber knob to its cellular receptor,
the coxsackievirus and Ad receptor (CAR), promotes virus attachment to
cells and is a major determinant of Ad tropism. Analysis of the
kinetics of binding of Ad type 5 (Ad5) fiber knob to the soluble
extracellular domains of CAR together (sCAR) and each immunoglobulin
(Ig) domain (IgV and IgC2) independently by surface plasmon resonance
demonstrated that the IgV domain is necessary and sufficient for
binding, and no additional membrane components are required to confer
high-affinity binding to Ad5 fiber knob. Four Ad5 fiber knob mutations,
Ser408Glu and Pro409Lys in the AB loop, Tyr477Ala in the DG loop, and
Leu485Lys in
strand F, effectively abolished high-affinity binding
to CAR, while Ala406Lys and Arg412Asp in the AB loop and Arg481Glu in
strand E significantly reduced the level of binding. Circular
dichroism spectroscopy showed that these mutations do not disorder the
secondary structure of the protein, implicating Ser408, Pro409, Tyr477,
and Leu485 as contact residues, with Ala406, Arg412, and Arg481 being
peripherally or indirectly involved in CAR binding. The critical
residues have exposed side chains that form a patch on the surface,
which thus defines the high-affinity interface for CAR. Additional
site-directed mutagenesis of Ad5 fiber knob suggests that the binding
site does not extend to the adjacent subunit or toward the edge of the
R sheet. These findings have implications for our understanding of the
biology of Ad infection, the development of novel Ad vectors for
targeted gene therapy, and the construction of peptide inhibitors of Ad infection.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|